UPXI Upexi Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: UPXI

Price (delayed)

$0.426

Market cap

$8.9M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.15

Enterprise value

$37.18M

Highlights
UPXI's revenue has soared by 75% YoY but it is down by 5% QoQ
The gross profit is up by 43% year-on-year but it has declined by 5% since the previous quarter
The company's EPS has shrunk by 145% YoY and by 31% QoQ
Upexi's quick ratio has shrunk by 66% YoY and by 41% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.cbd.io/
Peers: PRTS

Key stats

What are the main financial stats of UPXI
Market
Shares outstanding
20.89M
Market cap
$8.9M
Enterprise value
$37.18M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.34
Price to sales (P/S)
0.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.41
Earnings
Revenue
$91.21M
EBIT
-$20.57M
EBITDA
-$14.74M
Free cash flow
-$6.97M
Per share
EPS
-$1.15
Free cash flow per share
-$0.34
Book value per share
$1.25
Revenue per share
$4.49
TBVPS
$1.92
Balance sheet
Total assets
$62.16M
Total liabilities
$36.7M
Debt
$30.12M
Equity
$25.46M
Working capital
-$1.67M
Liquidity
Debt to equity
1.18
Current ratio
0.93
Quick ratio
0.3
Net debt/EBITDA
-1.92
Margins
EBITDA margin
-16.2%
Gross margin
37.5%
Net margin
-22.8%
Operating margin
-5.9%
Efficiency
Return on assets
-31.4%
Return on equity
-70.3%
Return on invested capital
-44.1%
Return on capital employed
-54.3%
Return on sales
-22.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

UPXI stock price

How has the Upexi stock price performed over time
Intraday
-5.33%
1 week
-13.06%
1 month
-20.82%
1 year
-89.58%
YTD
-63.28%
QTD
-26.68%

Financial performance

How have Upexi's revenue and profit performed over time
Revenue
$91.21M
Gross profit
$34.18M
Operating income
-$5.37M
Net income
-$20.8M
Gross margin
37.5%
Net margin
-22.8%
UPXI's revenue has soared by 75% YoY but it is down by 5% QoQ
The operating margin has surged by 57% year-on-year but it has declined by 7% since the previous quarter
The gross profit is up by 43% year-on-year but it has declined by 5% since the previous quarter
The net margin has declined by 40% since the previous quarter

Growth

What is Upexi's growth rate over time

Valuation

What is Upexi stock price valuation
P/E
N/A
P/B
0.34
P/S
0.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.41
The company's EPS has shrunk by 145% YoY and by 31% QoQ
UPXI's price to book (P/B) is 76% lower than its last 4 quarters average of 1.4
Upexi's equity has decreased by 31% YoY and by 8% QoQ
The price to sales (P/S) is 82% lower than the last 4 quarters average of 0.5
UPXI's revenue has soared by 75% YoY but it is down by 5% QoQ

Efficiency

How efficient is Upexi business performance
The company's return on sales has shrunk by 64% QoQ
UPXI's ROIC has plunged by 60% from the previous quarter
The ROE has contracted by 46% from the previous quarter
Upexi's return on assets has decreased by 40% QoQ

Dividends

What is UPXI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for UPXI.

Financial health

How did Upexi financials performed over time
The total assets is 69% greater than the total liabilities
Upexi's quick ratio has shrunk by 66% YoY and by 41% QoQ
UPXI's current ratio is down by 37% year-on-year and by 25% since the previous quarter
The debt is 18% greater than the equity
UPXI's debt to equity has soared by 62% year-on-year and by 16% since the previous quarter
Upexi's equity has decreased by 31% YoY and by 8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.